Backgrounds/Aims: Traditionally, surgically placed pancreatic drains are removed, at the discretion of the operating surgeon. Moving towards enhanced recovery after surgery (ERAS), we looked for predictors for early drain removal. The purpose of this paper was to establish which postoperative days' (POD) drain amylase is most predictive against post-operative pancreatic fistula (POPF). 
INTRODUCTION
Pancreatoduodenectomy (PD) is a challenging and complex surgery. Morbidity after PD is as high as 65%. 1 Pancreatic anastomosis is the Achilles heel of PD and determines surgical outcomes. Post-operative pancreatic fistula (POPF) occurs, in 5-30% of patients undergoing pancreatic resections. Incidence rates vary according to type of pancreatic resection, and definitions of POPF used. 2, 3 POPF is associated with significant morbidity such as intra-abdominal collections, intra-abdominal hemorrhage, and multi-organ failure. Associated mortality from POPF is 0-5%. 4 Internationally, much work has been done, to understand risk factors for POPF in an effort to prevent, reduce, diagnose early, and manage POPF effectively.
Contributory factors are multifactorial, including patient, disease, and procedure related factors. Patient-related factors include age, gender, jaundice, and malnutrition.
Disease-related factors include pancreatic pathology, pancreatic texture, pancreas fat content, pancreatic duct size, and pancreatic juice output. Procedure-related factors include operative time, resection type, anastomotic technique, and intraoperative blood loss. 1 Traditionally, surgeons leave behind drains in proximity to pancreatic anastomosis, to drain leaking contents and leave this for a variable period. The debate of 'to drain' or 'not to drain' following a major abdominal procedure, has endured for eternity and PD is no exception.
Proponents of drains quote 'it is safer to place a drain during an operation rather than after'. Opponents of drain quote 'drain drains away the confidence of a surgeon!' In a meta-analysis of one randomized trial and 7 observational studies including 2,690 patients, Zhou et al. 5 reported that prophylactic intra-peritoneal drainage after pancreatic resection appears to be unable to improve the postoperative course, and may be associated with more severe and higher rate of complication and increased POPF occurrence. However, due to bias in included studies, fur-ther randomized or propensity score matched studies are needed, prior to any recommendation to change clinical practice. A recent global survey of experienced pancreatic surgeons reported that 14% never leave drains, 27% use drains selectively, and, of those who place drains, 51%
reportedly removed drains early. 6 In a recent systematic review including 14 randomized and non-randomized studies comparing routine intra-abdominal drainage versus no drainage, selective drain use, and early versus late drain removal after pancreatectomy, with major complications as primary outcome, Villafane-Ferriol et al. 7 concluded that based on available evidence, the most conservative approach, pending further data, is routine placement of a drain and early removal, unless the patient's clinical course or drain fluid amylase concentration suggests a developing fistula.
Locally, it is our policy to insert two drains in proximity to the pancreatic anastomosis and these are kept for variable periods at the discretion of the operating surgeon; albeit all surgeons practice early removal of drains. With our unit moving towards enhanced recovery after surgery (ERAS), we evaluate predictors for early removal of drains, such that fit patients can be discharged earlier. 8, 9 The purpose of this project is to establish which postoperative day drain amylase is most accurate, in ruling out presence of pancreatic fistulas. The secondary end point is to examine other factors that increase odds of developing postoperative pancreatic fistula (POPF). 
MATERIALS AND METHODS

Patients
Surgery
All pancreatic resections were performed by 5 hepatopancreatobiliary surgery specialists
Octreotide is not routinely used in post-operative management of pancreatic resections in our institution.
However, in patients wherein the pancreas was soft, the pancreatic duct was small, or where pancreato-enteric anastomosis was deemed to be 'less ideal' intra-operatively, octreotide was selectively used by surgeons.
Length of stay was defined as duration of an episode of hospitalization, from the date of pancreatic resection, to the date the patient was discharged from the hospital.
Intervention was defined as any form of additional percutaneous or invasive procedure, that the patient had to undergo in addition to primary surgery, but not including surgical intervention. Re-operation was defined as an unplanned repeat operation related to primary surgery.
Re-admission was defined as a repeat admission within 30 days of discharge from the primary admission, wherein pancreatic resection was performed. Mortality within 30 days of pancreatic resection, and mortality within the same inpatient stay for pancreatic resection, were studied. 
RESULTS
Patient profiles
Patients' demographic and clinical profiles are described in Table 1 . There were a total of 126 pancreatoduodenectomies, 67 distal pancreatectomies, 2 pancreatic enucleations, and 1 central pancreatectomy (Table 2) . Table 2 ).
Outcomes
There were 93 patients with biochemical POPF, and 103 patients with no evidence of POPF. Ten of the patients with biochemical POPF, had significant POPF.
Median length of stay, was 11 days for both groups (Table 2) . Type of pancreatectomy, texture of pancreas, diameter of pancreatic duct, intra-operative blood loss, and use of octreotide, had no statistical impact on occurrence of POPF (Table 3) .
Patients with significant POPF had increased odds of being re-admitted (p＜0.01). They were also found to have statistically higher need for procedural intervention, as compared to those without POPF (p＜0.01). There was no significant difference in the need for re-operation (p=0.34) or inpatient death (p=0.36) ( Table 4) . Clinical outcome was examined in those with POPF Grades B and C (n=10), compared to those who had no POPF, or purely biochemical POPF (n=186) ( Table 4 ). Median length of stay was 12 days, for those with significant POPF compared to 11 days in those without.
One of 10 patients with POPF Grades B and C underwent re-operation for exploratory laparotomy and drainage of abdominal collection. Five of 186 patients with no significant POPF underwent a re-operation for haemostasis, This was not statistically significant.
There was also no statistical difference in occurrence of death in both groups. There were neither 30-day mortality nor inpatient mortality, from the group with POPF Grade B and C. This may be due to the small number (n=10). There was one 30-day mortality from the POPF Grade A group, and none from the no POPF group. The patient died from hypertensive heart disease. There were 3 other patients who had inpatient mortalities beyond 30 days, from the time of operation from the no POPF group.
Their primary cause of death was pneumonia.
POD 1 and 3 drain amylase values as negative predictive marker
Patients with drain amylase values lower than 3 times that of serum amylase values at POD 1 and 3, were assessed with greatest negative predictive value, for developing POPF Grades B and C at 98.7% (95% CI 0.93 to 1.00) ( Table 5 ).
Factors that increase odds of developing POPF Of the 196 patients who underwent pancreatic resections, 67 patients underwent distal pancreatectomy, and 126 patients underwent a PD.
8.95% (6 of 67) of patients who underwent a distal pancreatectomy, and 3.17% (4 of 126) patients who underwent a PD had significant POPF.
Patients who underwent distal pancreatectomy had 3 times the odds of having significant POPF, as compared to those who underwent a PD, but this was not statistically significant (p=0.10) ( Table 3 ).
Use of octreotide and intraoperative blood loss, did not appear to affect incidence of POPF.
Subgroup analysis
Further subgroup analysis of those who underwent PD, and distal pancreatectomies were performed.
Of 126 patients who underwent PD, there were 94 pancreato-jejunostomies (PJ), and 13 pancreato-gastrostomies (PG). Nineteen patients had no specified anastomosis.
There was no statistical difference in occurrence of POPF from the type of pancreto-enteric anastomosis performed (p=1.0). Median diameter of the pancreatic duct in patients with POPF was 2.5 mm, while it was 3mm in those who did not have POPF. A smaller pancreatic duct did and use of octreotide (p=1.0) also did not affect occurrence of POPF (Table 6) . (Table 6 ).
DISCUSSION
Using updated 2016 ISGPF criteria for POPF, incidence of POPF (Grades B and C) was 5.05% -Grade B POPF 4.55%, and Grade C 0.51%. This is lower than reported rates of 10-15.3%. 2, 14 When using the 2005 ISGPF definition, incidence of Grade A POPF was 42.3%.
The 2017 Cochrane review reported great variability in reporting of POPF, in terms of operative days and different cut-off values. 15 Some studies identified a patient with pancreatic fistula after radiological confirmation, before using ISGPF classification to stratify POPF. Others used drain amylase value cut-offs ＞1000 U/L to ＞4000 U/L on POD 1, to define POPF. 16 In our study, biochemistry was used as primary assessment for presence of POPF, and only patients with clinical signs and biochemically raised drain amylase value at POD 3 or after, had computed tomography to confirm presence of POPF.
We used the ISGPF definition of POPF in our study to predict for presence of POPF, having consistently stud- Molinari et al. 14 hospital. An earlier removal of surgically placed drains has also been reported to decrease rates of ascending infection, pancreatic fistula, and abdominal complications. 7, 18 Limitations of this study include the retrospective nature, varied practices among the 5 surgeons involved, single centre experience, span over 8 years during which various methods of resections and techniques as well as perioperative care have evolved. As a result, this study is also heterogeneous, including all types of pancreatic resections, and benign as well as malignant conditions.
Further subgroup analysis was performed on the two main subgroups -PD, and distal pancreatectomy -to enhance understanding of these common procedures.
Presence of POPF has adverse outcome on a patient's post pancreatic resection. We recommend routine drain amylase level measurements post pancreatic resection. contributing to enhanced recovery after surgery.
